Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions

Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin

Interventions

DRUG

sulfonylurease with metformin, DPP4 inhibitors with Metformin

Oral hypoglycemic agents

Trial Locations (1)

RECRUITING

BSMMU, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER